Vortioxetine
Indication
Major depressive episodes
NICE TA367 - Vortioxetine for treating major depressive episodes
Green
Brand:
Brintellix
Nice TA:
367
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Vortioxetine is recommended as an option for treating major depressive episodes in adults whose condition has responded inadequately to 2 antidepressants within the current episode.
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: